ARTICLE | Clinical News
Vismodegib regulatory update
January 2, 2012 8:00 AM UTC
EMA accepted for review an MAA from Roche for vismodegib to treat adults with advanced basal cell carcinoma for whom surgery is considered inappropriate. The MAA submission triggered a $6 million mile...